NIMGenetics offers a global solution to test for the etiopathogenesis of isolated epilepsy or epilepsy associated with other neurological and/or neurometabolic disorders: NIMNet® Epilepsy.
Paediatric neurology patients with neurodevelopmental and/or congenital disorders frequently suffer from concurrent epileptic seizures.
For these patients, NIMGenetics recommends a comprehensive approach: NIMIntegra® Neuropaediatrics.
Check our range of NGS genetic testing services for epilepsy here
Comprehensive approach to test for the different clinical forms of epilepsy, analysing over 250 clinically relevant genes using whole exome sequencing (ExoNIM®).
Genetic epilepsy test using ExoNIM®, our whole exome sequencing platform.
Array CGH specifically designed to test for autism spectrum disorder (ASD).
NIMGenetics offers genetic testing services based on different molecular biology techniques, including MLPA (Multiplex Ligation-dependent Probe Amplification) and TRP-PCR to test for triplet repeat expansions. We also offer specialists massive parallel sequencing and MLPA techniques to detect genetic alterations in the mitochondrial DNA.
